VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2, Journal of Cell Science, vol.116, issue.4, pp.665-74, 2003. ,
DOI : 10.1242/jcs.00286
Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes, Clinical Science, vol.102, issue.2, pp.187-94, 2002. ,
DOI : 10.1042/cs1020187
Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels, Circulation Research, vol.109, issue.5, pp.554-63, 2011. ,
DOI : 10.1161/CIRCRESAHA.111.243790
Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells, Nature Medicine, vol.9, issue.11, pp.1370-1376, 2003. ,
DOI : 10.1038/nm948
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications, Blood, vol.105, issue.4, pp.1383-95, 2005. ,
DOI : 10.1182/blood-2004-07-2909
Evidence for a Relationship between VEGF and BMI Independent of Insulin Sensitivity by Glucose Clamp Procedure in a Homogenous Group Healthy Young Men, PLoS ONE, vol.48, issue.1, p.12610, 2010. ,
DOI : 10.1371/journal.pone.0012610.t001
Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts, Clinical & Experimental Immunology, vol.279, issue.174, pp.573-582, 2007. ,
DOI : 10.1111/j.1365-2249.2006.03295.x
Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies, Nature Reviews Cancer, vol.14, issue.3, pp.182-94, 2009. ,
DOI : 10.1038/nrc2561
Endothelial-like cells derived from human CD14 positive monocytes, Differentiation, vol.65, issue.5, pp.287-300, 2000. ,
DOI : 10.1046/j.1432-0436.2000.6550287.x
CD14 Acts as an Angiogenic Factor by Inducing Basic Fibroblast Growth Factor (bFGF), Bull Korean Chem Soc, vol.28, issue.9, pp.1613-1617, 2007. ,
New functions for the matrix metalloproteinases in cancer progression, Nature Reviews Cancer, vol.78, issue.3, pp.161-74, 2002. ,
DOI : 10.1038/nrc745
Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2, Cancer Res, vol.60, issue.24, pp.7156-62, 2000. ,
Experimental metastasis is suppressed in MMP-9-deficient mice, Clinical & Experimental Metastasis, vol.17, issue.2, pp.177-81, 1999. ,
DOI : 10.1023/A:1006603723759
BAY 12?9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity, Clin Cancer Res, vol.5, issue.11, pp.3603-3610, 1999. ,
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis, Nat Cell Biol, vol.2, issue.10, pp.737-781, 2000. ,
Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I, Proceedings of the National Academy of Sciences, vol.97, issue.8, pp.4052-4059, 2000. ,
DOI : 10.1073/pnas.060037197
The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis, Trends in Cell Biology, vol.11, issue.11, pp.37-43, 2001. ,
DOI : 10.1016/S0962-8924(01)82222-4
Regulation of Matrix Metalloproteinase Activity in Ischemic Tissue by Interleukin-10: Role in Ischemia-Induced Angiogenesis, Circulation Research, vol.89, issue.3, pp.259-64, 2001. ,
DOI : 10.1161/hh1501.094269
Disulfide assignments in recombinant mouse and human interleukin 4, Biochemistry, vol.30, issue.6, pp.1515-1538, 1991. ,
DOI : 10.1021/bi00220a011
Interleukin-13 and Interleukin-4 Induce Vascular Endothelial Growth Factor Release from Airway Smooth Muscle Cells, American Journal of Respiratory Cell and Molecular Biology, vol.34, issue.2 ,
DOI : 10.1165/rcmb.2005-0147OC
Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis, Arthritis & Rheumatism, vol.81, issue.8, pp.2402-2416, 2006. ,
DOI : 10.1002/art.22034
The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases, Clinical Chemistry and Laboratory Medicine, vol.46, issue.6, pp.733-780, 2008. ,
DOI : 10.1515/CCLM.2008.178
Objectives, Design and Recruitment of a Familial and Longitudinal Cohort for Studying Gene-Environment Interactions in the Field of Cardiovascular Risk: The Stanislas Cohort, Clinical Chemistry and Laboratory Medicine, vol.36, issue.1, pp.35-42, 1998. ,
DOI : 10.1515/CCLM.1998.007
Development of a High-Throughput Automated Analyzer Using Biochip Array Technology, Clinical Chemistry, vol.51, issue.7, pp.1165-76, 2005. ,
DOI : 10.1373/clinchem.2005.049429
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, vol.18, issue.6, pp.499-502, 1972. ,
A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Research, vol.16, issue.3, p.1215, 1988. ,
DOI : 10.1093/nar/16.3.1215
A Multilocus Genotyping Assay for Cardiovascular Disease, Clinical Chemistry and Laboratory Medicine, vol.36, issue.8, pp.561-567, 1998. ,
DOI : 10.1515/CCLM.1998.096
Gene interactions and stroke risk in children with sickle cell anemia, Blood, vol.103, issue.6, pp.2391-2397, 2004. ,
DOI : 10.1182/blood-2003-09-3015
Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS, Nucleic Acids Research, vol.33, issue.4, p.38, 2005. ,
DOI : 10.1093/nar/gni038
Collection and Storage of Human Blood Cells for mRNA Expression Profiling: A 15-Month Stability Study, Clinical Chemistry, vol.51, issue.7, pp.1250-1252, 2005. ,
DOI : 10.1373/clinchem.2005.048546
A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese, Human Genetics, vol.103, issue.1, pp.65-74, 1998. ,
DOI : 10.1007/s004390050785
In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism, Pharmacogenetics, vol.11, issue.9, pp.809-823, 2001. ,
DOI : 10.1097/00008571-200112000-00009
I-TASSER server for protein 3D structure prediction, BMC Bioinformatics, vol.9, issue.1, p.40, 2008. ,
DOI : 10.1186/1471-2105-9-40
I-TASSER: a unified platform for automated protein structure and function prediction, Nature Protocols, vol.59, issue.4, pp.725-763, 2010. ,
DOI : 10.1038/nprot.2010.5
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses, The American Journal of Human Genetics, vol.81, issue.3, pp.559-75, 2007. ,
DOI : 10.1086/519795
Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer, Nitric Oxide, vol.25, issue.3, pp.338-381, 2011. ,
DOI : 10.1016/j.niox.2011.06.003
(Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration, European Journal of Neurology, vol.26, issue.Suppl. 1, pp.37-42, 2009. ,
DOI : 10.1111/j.1468-1331.2008.02335.x
Endothelial Nitric Oxide Synthase Gene Polymorphism and Acute Myocardial Infarction, Hypertension, vol.32, issue.3, pp.521-527, 1998. ,
DOI : 10.1161/01.HYP.32.3.521
Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298->Asp polymorphism) to the presence, extent, and severity of coronary artery disease, Heart, vol.87, issue.6, pp.525-533, 2002. ,
DOI : 10.1136/heart.87.6.525
Effect of the Asp298 Variant of Endothelial Nitric Oxide Synthase on Survival for Patients With Congestive Heart Failure, Circulation, vol.107, issue.12, pp.1598-602, 2003. ,
DOI : 10.1161/01.CIR.0000060540.93836.AA
Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians, Atherosclerosis, vol.193, issue.1, pp.135-176, 2007. ,
DOI : 10.1016/j.atherosclerosis.2006.05.041
Polymorphisms in the Paraoxonase and Endothelial Nitric Oxide Synthase Genes and the Risk of Early-Onset Myocardial Infarction, The American Journal of Cardiology, vol.99, issue.8, pp.1100-1105, 2007. ,
DOI : 10.1016/j.amjcard.2006.12.022
Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population, Cytokine, vol.61, issue.2, pp.602-609, 2013. ,
DOI : 10.1016/j.cyto.2012.10.024
NOSIP, a novel modulator of endothelial nitric oxide synthase activity, The FASEB Journal, vol.15, issue.1, pp.79-89, 2001. ,
DOI : 10.1096/fj.00-0078com
Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor, Am J Physiol Cell Physiol, vol.280, issue.6, pp.1375-86, 2001. ,
A Common Single Nucleotide Polymorphism in the CD14 Promoter Decreases the Affinity of Sp Protein Binding and Enhances Transcriptional Activity, The Journal of Immunology, vol.167, issue.10, pp.5838-5882, 2001. ,
DOI : 10.4049/jimmunol.167.10.5838
Genomewide Association Study Using a High-Density Single Nucleotide Polymorphism Array and Case-Control Design Identifies a Novel Essential Hypertension Susceptibility Locus in the Promoter Region of Endothelial NO Synthase, Hypertension, vol.59, issue.2, pp.248-55, 2012. ,
DOI : 10.1161/HYPERTENSIONAHA.111.181990
Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4, Proceedings of the National Academy of Sciences, vol.106, issue.7, pp.2348-52, 2009. ,
DOI : 10.1073/pnas.0808146106
IL-4 Is Proangiogenic in the Lung under Hypoxic Conditions, The Journal of Immunology, vol.182, issue.9, pp.5469-76, 2009. ,
DOI : 10.4049/jimmunol.0713347
Effect of In Situ Retroviral Interleukin-4 Transfer on Established Intracranial Tumors, JNCI Journal of the National Cancer Institute, vol.91, issue.5, pp.438-483, 1999. ,
DOI : 10.1093/jnci/91.5.438
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression, J Biol Chem, vol.271, issue.22, pp.13055-60, 1996. ,
Human endothelial gelatinases and angiogenesis, The International Journal of Biochemistry & Cell Biology, vol.33, issue.10, pp.960-70, 2001. ,
DOI : 10.1016/S1357-2725(01)00007-3
Does matrix metalloproteinase-3 polymorphism play a role in age-related macular degeneration in patients with myocardial infarction?, Medicina (Kaunas), vol.48, issue.8, pp.404-413, 2012. ,
Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study, Atherosclerosis, vol.206, issue.1, pp.265-274, 2009. ,
DOI : 10.1016/j.atherosclerosis.2009.01.031
A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C, The Journal of Lipid Research, vol.54, issue.2, pp.535-576, 2013. ,
DOI : 10.1194/jlr.P030551